Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease and the Risk of Nephrogenic Systemic Fibrosis: Radiology In Training

被引：7
作者：
Alabousi, Mostafa [1 ]
Davenport, Matthew S. [2 ,3 ]
机构：
[1] McMaster Univ, Dept Radiol, 1280 Main St W, Hamilton, ON L8S 4L8, Canada
[2] Michigan Med, Dept Radiol, Ann Arbor, MI USA
[3] Michigan Med, Dept Urol, Ann Arbor, MI USA
来源：
RADIOLOGY | 2021年 / 300卷 / 02期
关键词：
CONSENSUS STATEMENTS; AMERICAN-COLLEGE; LIVER-DISEASE; HEMODIALYSIS; SAFETY; AGENTS; EXPOSURE;
D O I：
10.1148/radiol.2021210044
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
A 66-year-old male patient with end-stage chronic kidney disease undergoing maintenance dialysis and with a history of group I intravenous gadolinium-based contrast media (GBCM) administration presented with clinical and pathologic findings consistent with nephrogenic systemic fibrosis. A summary of the evidence and recommendations for use of intravenous GBCM in patients with kidney disease is presented. (C) RSNA, 2021
引用
收藏
页码：279 / 284
页数：6
相关论文
共 47 条
  • [1] Nephrogenic Systemic Fibrosis and Gadolinium-Based Contrast Agents
    Abu-Alfa, Ali K.
    [J]. ADVANCES IN CHRONIC KIDNEY DISEASE, 2011, 18 (03) : 188 - 198
  • [2] Nephrogenic Systemic Fibrosis: Change in Incidence Following a Switch in Gadolinium Agents and Adoption of a Gadolinium Policy-Report from Two US Universities
    Altun, Ersan
    Martin, Diego R.
    Wertman, Rebecca
    Lugo-Somolinos, Aida
    Fuller, Edwin R., III
    Semelka, Richard C.
    [J]. RADIOLOGY, 2009, 253 (03) : 689 - 696
  • [3] American College of Radiology, 2020, MAN CONTR MED
  • [4] [Anonymous], ESUR Guidelines on Contrast Media version 10.0
  • [5] A Systematic Review of 639 Patients with Biopsy-confirmed Nephrogenic Systemic Fibrosis
    Attari, Hanieh
    Cao, Yan
    Elmholdt, Tina R.
    Zhao, Yize
    Prince, Martin R.
    [J]. RADIOLOGY, 2019, 292 (02) : 376 - 386
  • [6] Bennett Charles L, 2012, Clin Kidney J, V5, P82
  • [7] Quantification of gadolinium in fresh skin and serum samples from patients with nephrogenic systemic fibrosis
    Christensen, Kevin N.
    Lee, Christine U.
    Hanley, Matthew M.
    Leung, Nelson
    Moyer, Thomas P.
    Pittelkow, Mark R.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (01) : 91 - 96
  • [8] Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: Retrospective study of a renal replacement therapy cohort
    Collidge, Tara Anne
    Thomson, Peter Campbell
    Mark, Patrick Barry
    Traynor, James Phillip
    Jardine, Alan George
    Morris, Scott Thomas William
    Simpson, Keith
    Roditi, Giles Hannibal
    [J]. RADIOLOGY, 2007, 245 (01) : 168 - 175
  • [9] Risk of Nephrogenic Systemic Fibrosis from Gadoxetic Acid in Patients with Severe Kidney Disease
    Davenport, Matthew S.
    Shankar, Prasad R.
    [J]. RADIOLOGY, 2020, 297 (03) : 563 - 564
  • [10] Use of Intravenous Iodinated Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation
    Davenport, Matthew S.
    Perazella, Mark A.
    Yee, Jerry
    Dillman, Jonathan R.
    Fine, Derek
    McDonald, Robert J.
    Rodby, Roger A.
    Wang, Carolyn L.
    Weinreb, Jeffrey C.
    [J]. RADIOLOGY, 2020, 294 (03) : 660 - 668
12345